Merck & Co., Inc. (MRK)
NYSE·Healthcare·Drug Manufacturers - General
$109.93
-0.26%
Mkt Cap $289.58B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 3, 2026 | $16.20B | $16.40B | +1.24% | $2.01 | $2.04 | +1.49% | — | — |
| Q4 2025 Oct 30, 2025 | $16.98B | $17.28B | +1.75% | $2.36 | $2.58 | +9.32% | — | — |
| Q3 2025 Jul 29, 2025 | $15.86B | $15.81B | -0.37% | $2.03 | $2.13 | +4.93% | — | — |
| Q2 2025 Apr 24, 2025 | $15.34B | $15.53B | +1.24% | $2.13 | $2.22 | +4.23% | — | — |
| Q1 2025 Feb 4, 2025 | $15.48B | $15.62B | +0.91% | $1.85 | $1.72 | -7.03% | — | — |
| Q4 2024 Oct 31, 2024 | $16.47B | $16.66B | +1.11% | $1.50 | $1.57 | +4.67% | — | — |
| Q3 2024 Jul 30, 2024 | $15.87B | $16.11B | +1.53% | $2.15 | $2.28 | +6.05% | — | — |
| Q2 2024 Apr 25, 2024 | $15.21B | $15.78B | +3.75% | $1.88 | $2.07 | +10.11% | — | — |
| Q1 2024 Feb 1, 2024 | $14.50B | $14.63B | +0.91% | -$0.09 | $0.03 | +133.33% | — | — |
| Q4 2023 Oct 26, 2023 | $14.44B | $15.96B | +10.51% | $1.95 | $2.13 | +9.23% | — | — |
| Q3 2023 Aug 1, 2023 | $14.45B | $15.04B | +4.08% | -$2.17 | -$2.06 | +5.07% | — | — |
| Q2 2023 Apr 27, 2023 | $14.29B | $14.49B | +1.37% | $1.32 | $1.40 | +6.06% | — | — |
| Q1 2023 Feb 2, 2023 | $13.66B | $13.83B | +1.26% | $1.56 | $1.62 | +3.85% | — | — |
| Q4 2022 Oct 27, 2022 | $14.07B | $14.96B | +6.35% | $1.67 | $1.85 | +10.78% | — | — |
| Q3 2022 Jul 28, 2022 | $13.86B | $14.59B | +5.32% | $1.70 | $1.87 | +10.00% | — | — |
| Q2 2022 Apr 28, 2022 | $14.56B | $15.90B | +9.24% | $1.83 | $2.14 | +16.94% | — | — |
| Q1 2022 Feb 3, 2022 | $13.16B | $13.52B | +2.78% | $1.53 | $1.80 | +17.65% | — | — |
| Q4 2021 Oct 28, 2021 | $12.32B | $13.15B | +6.73% | $1.55 | $1.75 | +12.90% | — | — |
| Q3 2021 Jul 29, 2021 | $11.40B | $11.40B | +0.00% | $1.33 | $1.31 | -1.50% | — | — |
| Q2 2021 Apr 29, 2021 | $13.78B | $10.63B | -22.91% | $1.63 | $1.40 | -14.11% | — | — |